[ XXXX : screening--early detection].

@entity5 @entity1 @entity6523 @entity14
@entity14 is the second leading @entity5 in Germany. The mortality is still 60%. 75% of the @entity1 have no risk factors for @entity14 , 18% have a positive family history for the disease. In these @entity1 @entity14 arise from benign @entity6523 . A 76-90% reduction in @entity14 incidence can be achieved by endoscopic polypectomy. @entity5 stage is an important determinant of outcome. In Dukes stage A the overall survival rate is over 90%. By annual fecal occult blood test the incidence and mortality rate of @entity14 can be reduced significantly. The combination of fecal occult blood test and flexible sigmoidoscopy seems to be more effective. An alternative strategy is a colonoscopy every ten years. But the important problem in Germany is the very low compliance of the @entity1 . Only 16% of the @entity1 and 34% of the @entity1 are participating in @entity5 surveillance program.
